Premium
PUVA Therapy is Preferable to UVB Phototherapy in the Management of HIV‐Associted Dermatoses
Author(s) -
Morison Warwick L.
Publication year - 1996
Publication title -
photochemistry and photobiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.818
H-Index - 131
eISSN - 1751-1097
pISSN - 0031-8655
DOI - 10.1111/j.1751-1097.1996.tb02456.x
Subject(s) - methoxsalen , puva therapy , dermatology , medicine , human immunodeficiency virus (hiv) , antiretroviral therapy , vitiligo , clinical trial , psoriasis , immunology , pathology , viral load
Both methoxsalen plus UVA (PUVA) therapy and UVB phototherapy are commonly used in the management of human immunodeficiency virus‐associated dermatoses but UVB phototherapy appears to be the preferred treatment. There are several considerations, in particular therapeutic efficacy and therapeutic profile, which suggest that PUVA therapy might be more effective, This needs to be established in clinical trials.